Literature DB >> 22989468

Medullary thyroid carcinoma: the influence of policy changing in clinical characteristics and disease progression.

Maria Alevizaki1, Katerina Saltiki, Gianna Rentziou, Alexandra Papathoma, Leda Sarika, Vasiliki Vasileiou, Eleni Anastasiou.   

Abstract

OBJECTIVE: Medullary thyroid carcinoma (MTC) has varying clinical course. We assessed trends in MTC presentation during the last 34 years.
DESIGN: Retrospective study.
METHODS: One hundred and fifty one patients (44.4% males) were followed for 0.934 years. Patients were classified according to year of diagnosis: group 1, 1977-2000 (n=53) and group 2, 2001-2011 (n=98). Extent of disease at diagnosis, during follow-up, number of surgeries, and pre- and postoperative calcitonin levels were recorded.
RESULTS: In total, 48.34% reported family history of MTC. Group 1 had larger tumors (median 1.70 (intraquartile range (IQR) 1.7) vs 1.1 (1.2) cm, P=0.045, Mann-Whitney), they presented less frequently micro-MTCs (27.8 vs 46.1%, P=0.045), and underwent more multiple surgeries (63.3 vs 20.0%, P<0.001). Group 1 had more frequently progressive disease (35.8 vs 12.2%, P=0.003) and distant metastasis at follow-up (39.7 vs 17.4%, P=0.017). Chronological group (HR 0.15, 95% CI 0.03-0.68, P=0.015) and distant metastases at follow-up (HR 0.07, 95% CI 0.015-0.30, P=0.001) were independently associated with 10-year disease progression (P<0.001). In sporadic cases, cervical lymph node invasion and distant metastases at diagnosis were more frequent in group 1 (72.7 vs 45.5%, P=0.032 and 27.3 vs 5%, P=0.019 respectively); disease stage at diagnosis was more advanced (P=0.004). They underwent more multiple surgeries (P<0.001), presented more frequently distant metastasis at follow-up (67.7 vs 20.0%, P=0.002), had less frequently remission, and more frequently progressive disease (21.4 vs 58.0% and 64.3 vs 14.0% respectively, P<0.001). Postoperative calcitonin levels were higher (P=0.024).
CONCLUSIONS: Recently, an increase in micro-MTCs is observed, while indices of invasiveness and persistence of disease are better. Increased awareness in familial cases, routine calcitonin measurements, and improved surgical procedures could be responsible.

Entities:  

Mesh:

Year:  2012        PMID: 22989468     DOI: 10.1530/EJE-12-0388

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

1.  Treating medullary thyroid carcinoma in a tertiary center. Current trends and review of the literature.

Authors:  E Prokopakis; M Doulaptsi; A Kaprana; S Velegrakis; Y Vlastos; G Velegrakis
Journal:  Hippokratia       Date:  2014-04       Impact factor: 0.471

Review 2.  Metachronous appearance of second malignancies in medullary thyroid carcinoma (MTC) patients: a diagnostic challenge and brief review of the literature.

Authors:  Maria Alevizaki; Elena Kyratzoglou; Aristoteles Bamias; Marinella Tzanela; Meletios A Dimopoulos; Katerina Saltiki
Journal:  Endocrine       Date:  2013-04-23       Impact factor: 3.633

3.  Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.

Authors:  Hans Hg Verbeek; Jan Willem B de Groot; Wim J Sluiter; Anneke C Muller Kobold; Edwin R van den Heuvel; John Tm Plukker; Thera P Links
Journal:  Cochrane Database Syst Rev       Date:  2020-03-16

4.  RET Proto-oncogene Gene Mutation Is Related to Cervical Lymph Node Metastasis in Medullary Thyroid Carcinoma.

Authors:  Sisi Wang; Bo Wang; Chao Xie; Daoxiong Ye
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

5.  Prognostic significance and optimal cutoff of age in medullary thyroid cancer.

Authors:  Ning Qu; Rong-Liang Shi; Ting-Xian Luo; Yu-Long Wang; Duan-Shu Li; Yu Wang; Cai-Ping Huang; Qing-Hai Ji
Journal:  Oncotarget       Date:  2016-03-29

6.  Recurrent spinal metastasis of a sporadic medullary carcinoma of the thyroid after radiation therapy: a case report and review of the literature.

Authors:  Christopher Munoz-Bendix; Antonio Santacroce; Kristin Gierga; Frank W Floeth; Hans-Jakob Steiger; Marco Antonio Penalonzo; Sven Oliver Eicker
Journal:  Clin Case Rep       Date:  2015-11-09

7.  Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.

Authors:  Ning Qu; Rong-Liang Shi; Zhong-Wu Lu; Tian Liao; Duo Wen; Guo-Hua Sun; Duan-Shu Li; Qing-Hai Ji
Journal:  Oncotarget       Date:  2016-10-04

8.  Medullary thyroid carcinoma (MTC): unusual metastatic sites.

Authors:  Paraskevi Kazakou; George Simeakis; Maria Alevizaki; Katerina Saltiki
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.